These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
408 related articles for article (PubMed ID: 25262690)
41. Prognostic value of primary tumor FDG uptake for occult mediastinal lymph node involvement in clinically N2/N3 node-negative non-small cell lung cancer. Trister AD; Pryma DA; Xanthopoulos E; Kucharczuk J; Sterman D; Rengan R Am J Clin Oncol; 2014 Apr; 37(2):135-9. PubMed ID: 23111361 [TBL] [Abstract][Full Text] [Related]
42. The role of (18)F-FDG PET/CT for evaluation of metastatic mediastinal lymph nodes in patients with lung squamous-cell carcinoma or adenocarcinoma. Lu P; Sun Y; Sun Y; Yu L Lung Cancer; 2014 Jul; 85(1):53-8. PubMed ID: 24792334 [TBL] [Abstract][Full Text] [Related]
43. [Risk factor analysis of mediastinal lymph node metastasis in non-small cell lung cancer patients and the strategy of mediastinoscopy prior to surgery]. Wang X; Zheng L; Zhang SY; Xie ZM; Yu H; Su XD; Wang JY; Huang ZF; Yang MT; Rong TH Zhonghua Zhong Liu Za Zhi; 2009 Jun; 31(6):456-9. PubMed ID: 19950559 [TBL] [Abstract][Full Text] [Related]
44. Endoscopic ultrasound-guided fine needle aspiration of mediastinal lymph node in patients with suspected lung cancer after positron emission tomography and computed tomography scans. Eloubeidi MA; Cerfolio RJ; Chen VK; Desmond R; Syed S; Ojha B Ann Thorac Surg; 2005 Jan; 79(1):263-8. PubMed ID: 15620955 [TBL] [Abstract][Full Text] [Related]
45. Thoracic staging in lung cancer: prospective comparison of 18F-FDG PET/MR imaging and 18F-FDG PET/CT. Heusch P; Buchbender C; Köhler J; Nensa F; Gauler T; Gomez B; Reis H; Stamatis G; Kühl H; Hartung V; Heusner TA J Nucl Med; 2014 Mar; 55(3):373-8. PubMed ID: 24504054 [TBL] [Abstract][Full Text] [Related]
46. [Preliminary study of 18F-FDG PET-CT in defining lymph node radiation target volume for non-small-cell lung cancer patients]. Liu LP; Yu JM; Guo HB; Fu Z; Han AQ; Yang GR Zhonghua Zhong Liu Za Zhi; 2007 Jun; 29(6):453-6. PubMed ID: 17974282 [TBL] [Abstract][Full Text] [Related]
48. [Clinical characteristics and treatment outcome of 36 cases with non-Hodgkin's lymphoma arising from mediastinum in children]. Tang YJ; Tang JY; Pan C; Xue HL; Chen J; Shen SH; Dong L; Zhou M; Wang YP; Gu LJ; Jiang H; Ye QD Zhonghua Er Ke Za Zhi; 2009 Sep; 47(9):687-90. PubMed ID: 20021793 [TBL] [Abstract][Full Text] [Related]
49. [Clinical analysis of seven cases of pulmonary malignant tumors in children]. Xu D; Chen ZM; Gu WZ; Wang YS; Huang MX; Tang LF; Zhang YY; Jiang Y Zhonghua Er Ke Za Zhi; 2017 Apr; 55(4):298-303. PubMed ID: 28441828 [No Abstract] [Full Text] [Related]
50. The pulmonary manifestations of AIDS-related non-Hodgkin's lymphoma. Eisner MD; Kaplan LD; Herndier B; Stulbarg MS Chest; 1996 Sep; 110(3):729-36. PubMed ID: 8797419 [TBL] [Abstract][Full Text] [Related]
51. AIDS-related primary pulmonary lymphoma. Ray P; Antoine M; Mary-Krause M; Lebrette MG; Wislez M; Duvivier C; Meyohas MC; Girard PM; Mayaud C; Cadranel J Am J Respir Crit Care Med; 1998 Oct; 158(4):1221-9. PubMed ID: 9769285 [TBL] [Abstract][Full Text] [Related]
52. Using PET-CT in the restaging of primitive mediastinal B-cell lymphoma (PMBCL) after chemotherapy: which criteria should we use? Giunta F; Zotta M; Menga M; Balma M; Bellò M; Passera R; Filippi AR; Chiappella A; Ladetto M; Ricardi U; Vitolo U; Bisi G Q J Nucl Med Mol Imaging; 2015 Jun; 59(2):214-9. PubMed ID: 25669764 [TBL] [Abstract][Full Text] [Related]
53. Impact of ¹⁸F-FDG PET/CT for detecting recurrence of medullary thyroid carcinoma. Ozkan E; Soydal C; Kucuk ON; Ibis E; Erbay G Nucl Med Commun; 2011 Dec; 32(12):1162-8. PubMed ID: 21946617 [TBL] [Abstract][Full Text] [Related]
54. The value of (18)F-fluorodeoxyglucose positron emission tomography/computed tomography for staging of primary extranodal head and neck lymphomas. Schrepfer T; Haerle SK; Strobel K; Schaefer N; Hälg RA; Huber GF Laryngoscope; 2010 May; 120(5):937-44. PubMed ID: 20422687 [TBL] [Abstract][Full Text] [Related]
56. [Comparison of ¹⁸F-FDG PET/CT and large-scale DWI for evaluation of non-Hodgkin lymphoma bone marrow infiltration]. Tang R; Gui S; Li J; Zhang H; Lu B; Yang P; Fu D; Fu W; Li W; Cai L Zhonghua Xue Ye Xue Za Zhi; 2014 Mar; 35(3):231-5. PubMed ID: 24666490 [TBL] [Abstract][Full Text] [Related]
57. Integrated FDG-PET/CT does not make invasive staging of the intrathoracic lymph nodes in non-small cell lung cancer redundant: a prospective study. Tournoy KG; Maddens S; Gosselin R; Van Maele G; van Meerbeeck JP; Kelles A Thorax; 2007 Aug; 62(8):696-701. PubMed ID: 17687098 [TBL] [Abstract][Full Text] [Related]
58. Primary Pulmonary Lymphoma: A Retrospective Analysis of 27 Cases in a Single Tertiary Hospital. Zhang XY; Gu DM; Guo JJ; Su QQ; Chen YB Am J Med Sci; 2019 Apr; 357(4):316-322. PubMed ID: 30904047 [TBL] [Abstract][Full Text] [Related]
59. Biopsy findings in PET/CT-positive lung lesions in a community hospital. Lobrano MB; Hayman E; Dekelbaum M; Campeau R J La State Med Soc; 2005; 157(6):319-24. PubMed ID: 16579344 [TBL] [Abstract][Full Text] [Related]
60. Prognostic factors of Chinese patients with primary pulmonary non-Hodgkin's lymphoma: the single-institute experience in Taiwan. Hu YH; Hsiao LT; Yang CF; Chiou TJ; Liu JH; Gau JP; Yen CC; Chou TY; Hsu WH; Chen PM; Tzeng CH Ann Hematol; 2009 Sep; 88(9):839-46. PubMed ID: 19139892 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]